Trimurthi Limited

TRIMURTHI6

INE314I01036

Investment Banking & Brokerage Services

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-07-01 EDT			5-day change	1st Jan Change
18.94 ^INR	0.00%		0.00%	+68.36%

06-25	Trimurthi Limited announced that it has received INR 18.5 million in funding	CI
06-11	Trimurthi Limited announced that it expects to receive INR 19 million in funding	CI

Trimurthi Drugs & Pharmaceuticals Limited Announces Resignation of Priyanka Barve, Independent Director

March 30, 2016 at 10:02 am

Trimurthi Drugs & Pharmaceuticals Limited announced that the company has received a resignation letter from independent director - Priyanka Barve and has taken note of it.

Latest news about Trimurthi Limited

Trimurthi Limited announced that it has received INR 18.5 million in funding	06-24	CI
Trimurthi Limited announced that it expects to receive INR 19 million in funding	06-10	CI
Trimurthi Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-28	CI
Trimurthi Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-28	CI
Srinidhi Fine-Chemicals LLP along with vupparapalli chandrashekar reddy entered into share purchase agreement to acquire 49.71% stake in Trimurthi Limited from group of sellers for INR 50.7 million.	03-04	CI
Srinidhi Fine-Chemicals LLP and Vupparapalli Chandrasekhar Reddy made an offer to acquire 26% stake in Trimurthi Limited for INR26.5 million.	03-04	CI
Trimurthi Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-29	CI
Trimurthi Narrows Net Loss in Fiscal Q2	23-10-17	MT
Trimurthi Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-16	CI
Trimurthi Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-09-07	CI
Trimurthi Names Chairman	23-08-10	MT
Trimurthi Limited Announces Directorate Changes	23-08-09	CI
Trimurthi Limited Announces Managing Director Changes	23-08-09	CI
Trimurthi Divests Entire Stake in Curova India	23-03-16	MT
Arun Kumar Bhangadia completed the acquisition of 25% stake in Curova India LLP.	23-03-15	CI
Trimurthi Completes Sale of Wholly-Owned Subsidiary	22-10-04	MT
Trimurthi Limited acquired Trimurthi Pharmaceuticals Private Limited for approximately INR 4 million.	22-10-03	CI
Trimurthi Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-10	CI
Trimurthi Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-28	CI
Arun Kumar Bhangadia agreed to acquire 25% stake in Curova India LLP for INR 3.25 million.	22-07-27	CI
Trimurthi Limited Appoints Monam Kapoor as Additional Director	22-06-07	CI
Trimurthi Completes Sale of Wholly-Owned Arm	22-03-28	MT
Trimurthi Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-12	CI
Trimurthi Limited Announces Board and Committee Changes	22-02-12	CI
Trimurthi Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI

Trimurthi Limited is an India-based company, which is engaged in the business of trading of pharmaceuticals and related products and is into the business of trading of shares and securities. The Company's segments include Pharma Business, Financial Services, Investments, Trading in Shares and Foods. Its services include distribution network for pharmaceutical products, retail pharmacy and marketing. Its products include T-SIF-O, Polyflic XT, Ulcizole-DSR, Auscomin-S, T-SIF 200, ACLO-P, LAMITAB, Oriflox, Treb-DSR, Conplus and Volivia Gold.

Sector

Investment Banking & Brokerage Services

Calendar

2024-08-06 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Banking & Brokerage Services

	1st Jan change	Capi.
TRIMURTHI LIMITED	+68.36%	2.27M
MORGAN STANLEY	+7.45%	163B
THE GOLDMAN SACHS GROUP, INC.	+21.30%	159B
CHARLES SCHWAB	+7.75%	136B
CITIGROUP INC.	+25.31%	123B
CITIC SECURITIES COMPANY LIMITED	-11.44%	34.02B
RAYMOND JAMES FINANCIAL, INC.	+8.28%	25.02B
LPL FINANCIAL HOLDINGS INC.	+22.74%	20.87B
CSC FINANCIAL CO., LTD.	-20.43%	17.5B
NOMURA HOLDINGS, INC.	+50.38%	17.71B